Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 9, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 91
- −10 vs. Q3 2023
- Portfolio value
- $2.93B
- +$639.5M (+27.9%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CAVACava Group, Inc. | COM | 32,007,990 | $1.38B | 46.9% | 00.0% | Unchanged | History |
| SRRKScholar Rock Holding Corp | COM | 11,259,438 | $211.7M | 7.2% | +2,199,931+24.3% | Added | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 117,553,284 | $179.9M | 6.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 1,214,284 | $101.4M | 3.5% | −304,547−20.1% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,421,346 | $85.1M | 2.9% | −243,226−14.6% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 404,480 | $73.0M | 2.5% | +546+0.1% | Added | History |
| KYMRKymera Therapeutics, Inc. | COM | 2,530,735 | $64.4M | 2.2% | +725,389+40.2% | Added | History |
| MORFMorphic Holding, Inc. | COM | 2,138,188 | $61.8M | 2.1% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 1,615,348 | $59.0M | 2.0% | −201,272−11.1% | Reduced | History |
| SLNSilence Therapeutics plc | ADS | 3,000,000 | $52.1M | 1.8% | +500,000+20.0% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 1,695,949 | $48.6M | 1.7% | −833,788−33.0% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 116,388 | $44.3M | 1.5% | +116,388 | New | History |
| NMRANeumora Therapeutics, Inc. | COM | 2,552,702 | $43.5M | 1.5% | −250,000−8.9% | Reduced | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,028,255 | $31.5M | 1.1% | +1,022,815+18,801.7% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,026,364 | $28.8M | 1.0% | −2,036,203−50.1% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 3,100,422 | $25.8M | 0.9% | +578,178+22.9% | Added | History |
| KURAKura Oncology, Inc. | COM | 1,768,056 | $25.4M | 0.9% | −250,000−12.4% | Reduced | History |
| SLRNACELYRIN, Inc. | COM | 3,035,888 | $22.6M | 0.8% | +566,609+22.9% | Added | History |
| CBIOCrescent Biopharma, Inc. | COM | 8,589,064 | $20.3M | 0.7% | 00.0% | Unchanged | History |
| KRROKorro Bio, Inc. | COM | 418,605 | $20.1M | 0.7% | +418,605 | New | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 2,505,013 | $19.5M | 0.7% | +1,029,269+69.7% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 501,360 | $18.2M | 0.6% | +501,360 | New | History |
| DNLIDenali Therapeutics Inc. | COM | 802,899 | $17.2M | 0.6% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 1,217,960 | $16.2M | 0.6% | +402,875+49.4% | Added | History |
| WVEWave Life Sciences, Inc. | SHS | 3,007,400 | $15.2M | 0.5% | +1,007,400+50.4% | Added | History |
| SESea Ltd | SPONSORD ADS | 372,000 | $15.1M | 0.5% | −25,000−6.3% | Reduced | History |
| HARPHarpoon Therapeutics, Inc. | COM NEW | 1,304,127 | $14.8M | 0.5% | +1,204,127+1,204.1% | Added | History |
| AGENAgenus Inc | COM NEW | 15,631,235 | $12.9M | 0.4% | 00.0% | Unchanged | History |
| NTRANatera, Inc. | COM | 200,000 | $12.5M | 0.4% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 1,000,000 | $11.2M | 0.4% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 12,058,968 | $11.0M | 0.4% | +5,659,149+88.4% | Added | History |
| SDGRSchrodinger, Inc. | COM | 300,000 | $10.7M | 0.4% | −200,000−40.0% | Reduced | History |
| ERASErasca, Inc. | COM | 4,721,194 | $10.1M | 0.3% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,005,500 | $9.66M | 0.3% | −719,500−41.7% | Reduced | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $9.21M | 0.3% | 00.0% | Unchanged | History |
| LXEOLexeo Therapeutics, Inc. | COM | 603,435 | $8.10M | 0.3% | +603,435 | New | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,012,500 | $8.06M | 0.3% | +1,012,500 | New | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $8.05M | 0.3% | 00.0% | Unchanged | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 303,600 | $7.17M | 0.2% | +303,600 | New | History |
| TSMTaiwan Semiconductor Manufacturing Co Ltd | ADR | 67,999 | $7.07M | 0.2% | −34,700−33.8% | Reduced | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 3,663,104 | $6.48M | 0.2% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 9,136,635 | $6.30M | 0.2% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,811,191 | $6.12M | 0.2% | −96,944−5.1% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,046,517 | $5.75M | 0.2% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM NEW | 909,219 | $5.58M | 0.2% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 2,347,424 | $5.28M | 0.2% | −340,591−12.7% | Reduced | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $5.11M | 0.2% | 00.0% | Unchanged | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 924,771 | $5.01M | 0.2% | 00.0% | Unchanged | History |
| PDDPDD Holdings Inc. | SPONSORED ADS | 32,500 | $4.75M | 0.2% | +32,500 | New | History |
| FHTXFoghorn Therapeutics Inc. | COM | 720,720 | $4.65M | 0.2% | −1,000,000−58.1% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $4.64M | 0.2% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 5,666,410 | $4.59M | 0.2% | 00.0% | Unchanged | History |
| KLRSKalaris Therapeutics, Inc. | COM | 6,597,167 | $4.49M | 0.2% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $4.38M | 0.1% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 500,000 | $4.21M | 0.1% | 00.0% | Unchanged | History |
| BEKEKE Holdings Inc. | SPONSORED ADS | 250,000 | $4.05M | 0.1% | −25,000−9.1% | Reduced | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 1,323,530 | $3.98M | 0.1% | −1,209,515−47.7% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 86,600 | $3.53M | 0.1% | +86,600 | New | History |
| TRMLTourmaline Bio, Inc. | COM | 91,426 | $2.39M | 0.1% | +91,426 | New | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $2.00M | 0.1% | 00.0% | Unchanged | – |
| IMAImageneBio, Inc. | COM | 999,513 | $1.97M | 0.1% | −850,000−46.0% | Reduced | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $1.93M | 0.1% | 00.0% | Unchanged | History |
| AMZNAmazon Com Inc | Stock | 12,000 | $1.82M | 0.1% | 00.0% | Unchanged | History |
| BZKanzhun Ltd | SPONSORED ADS | 100,000 | $1.66M | 0.1% | −120,000−54.5% | Reduced | History |
| CRISCuris Inc | COM | 105,000 | $1.34M | <0.1% | 00.0% | Unchanged | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 110,532 | $1.26M | <0.1% | 00.0% | Unchanged | History |
| GOOGLAlphabet Inc. | Stock | 7,800 | $1.09M | <0.1% | +2,300+41.8% | Added | History |
| KRONKronos Bio, Inc. | COM | 842,954 | $1.05M | <0.1% | −700,000−45.4% | Reduced | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 50,759 | $967.0K | <0.1% | −1,142,271−95.7% | Reduced | History |
| MSFTMicrosoft Corp | Stock | 2,500 | $940.0K | <0.1% | −3,000−54.5% | Reduced | History |
| DDOGDatadog, Inc. | CL A COM | 7,500 | $910.0K | <0.1% | −4,000−34.8% | Reduced | History |
| INTAIntapp, Inc. | COM | 17,500 | $665.0K | <0.1% | +7,500+75.0% | Added | History |
| PCORProcore Technologies, Inc. | COM | 9,500 | $658.0K | <0.1% | +5,000+111.1% | Added | History |
| VVisa Inc. | Stock | 2,500 | $651.0K | <0.1% | −5,000−66.7% | Reduced | History |
| CRBUCaribou Biosciences, Inc. | COM | 105,347 | $604.0K | <0.1% | 00.0% | Unchanged | History |
| MEHCQChrome Holding Co. | CLASS A COM | 661,009 | $604.0K | <0.1% | 00.0% | Unchanged | History |
| LLYEli Lilly & Co | Stock | 1,000 | $583.0K | <0.1% | +1,000 | New | History |
| PEGAPegasystems Inc | COM | 11,500 | $562.0K | <0.1% | +4,000+53.3% | Added | History |
| RELYRemitly Global, Inc. | COM | 25,000 | $486.0K | <0.1% | +25,000 | New | History |
| KRSAKorsana Biosciences, Inc. | Stock | 138,955 | $466.0K | <0.1% | +552+0.4% | Added | History |
| CFLTConfluent, Inc. | CLASS A COM | 19,000 | $445.0K | <0.1% | +19,000 | New | History |
| MDBMongoDB, Inc. | CL A | 1,000 | $409.0K | <0.1% | +1,000 | New | History |
| CWANClearwater Analytics Holdings, Inc. | CL A | 20,000 | $401.0K | <0.1% | +20,000 | New | History |
| AMDAdvanced Micro Devices Inc | Stock | 2,500 | $369.0K | <0.1% | −3,500−58.3% | Reduced | History |
| DLOdLocal Ltd | CLASS A COM | 20,000 | $354.0K | <0.1% | +20,000 | New | History |
| PYPLPayPal Holdings, Inc. | Stock | 5,000 | $307.0K | <0.1% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $248.0K | <0.1% | 00.0% | Unchanged | History |
| HIPOHippo Holdings Inc. | COM NEW | 24,000 | $219.0K | <0.1% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 5,041 | $214.0K | <0.1% | −1,633,817−99.7% | Reduced | History |
| SNTISenti Biosciences Holdings, Inc. | COM | 55,555 | $37.0K | <0.1% | 00.0% | Unchanged | History |
| INKTMiNK Therapeutics, Inc. | COM | 1,916 | $2.00K | <0.1% | 00.0% | Unchanged | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q3 2023 (25)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 2,024,226 | $88.2M | 3.8% | History |
| IMGNImmunoGen, Inc. | COM | 1,512,113 | $24.0M | 1.0% | History |
| VTYXVentyx Biosciences, Inc. | COM | 405,239 | $14.1M | 0.6% | History |
| RYZBRayzeBio, Inc. | COM | 555,556 | $12.3M | 0.5% | History |
| GERNGeron Corp | COM | 5,565,889 | $11.8M | 0.5% | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $8.75M | 0.4% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 276,077 | $8.73M | 0.4% | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $7.77M | 0.3% | History |
| VRDNViridian Therapeutics, Inc. | COM | 504,978 | $7.75M | 0.3% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 500,000 | $6.13M | 0.3% | History |
| VERVVerve Therapeutics, Inc. | COM | 300,000 | $3.98M | 0.2% | History |
| TRMLTourmaline Bio, Inc. | COM | 914,262 | $2.57M | 0.1% | History |
| Avidity Biosciences, Inc.05370A108 | COM | 300,000 | $1.91M | 0.1% | – |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $1.12M | <0.1% | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,133,775 | $884.0K | <0.1% | History |
| XYZBlock, Inc. | CL A | 15,500 | $686.0K | <0.1% | History |
| NFLXNetflix Inc | Stock | 1,285 | $485.0K | <0.1% | History |
| CRWDCrowdStrike Holdings, Inc. | Stock | 2,000 | $335.0K | <0.1% | History |
| LVTXLAVA Therapeutics NV | SHS | 200,000 | $294.0K | <0.1% | History |
| BEAMBeam Therapeutics Inc. | COM | 10,975 | $264.0K | <0.1% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 936 | $166.0K | <0.1% | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $129.0K | <0.1% | History |
| KAKineta, Inc. | COM | 31,055 | $106.0K | <0.1% | History |
| PLRXPliant Therapeutics, Inc. | COM | 1,490 | $26.0K | <0.1% | History |
| KRSAKorsana Biosciences, Inc. | COM | 552 | $2.00K | <0.1% | History |